These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24341810)

  • 1. Casein-based micelles: a novel vector for delivery of the poorly soluble anticancer drug, flutamide?
    Elgindy NA; Samy WA; Elzoghby AO
    Ther Deliv; 2014 Jan; 5(1):7-9. PubMed ID: 24341810
    [No Abstract]   [Full Text] [Related]  

  • 2. Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats.
    Elzoghby AO; Saad NI; Helmy MW; Samy WM; Elgindy NA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):444-51. PubMed ID: 23872177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorinated and pegylated polyaspartamide derivatives to increase solubility and efficacy of Flutamide.
    Piccionello AP; Pitarresi G; Pace A; Triolo D; Picone P; Buscemi S; Giammona G
    J Drug Target; 2012 Jun; 20(5):433-44. PubMed ID: 22533704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model.
    Elzoghby AO; Helmy MW; Samy WM; Elgindy NA
    Pharm Res; 2013 Oct; 30(10):2654-63. PubMed ID: 23739989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: formulation, characterization, and in vivo pharmacokinetics.
    Elzoghby AO; Helmy MW; Samy WM; Elgindy NA
    Eur J Pharm Biopharm; 2013 Aug; 84(3):487-96. PubMed ID: 23403015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papain Mediated Synthesized Gold Nanoparticles Encore the Potency of Bioconjugated Flutamide.
    Xu X; Man L
    Curr Pharm Biotechnol; 2021; 22(4):557-568. PubMed ID: 32106799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein-based formulations as promising controlled release drug delivery systems.
    Elzoghby AO; El-Fotoh WS; Elgindy NA
    J Control Release; 2011 Aug; 153(3):206-16. PubMed ID: 21338636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of flutamide-carrier systems. Part 1: Preparation and evaluation of flutamide systems with polyvinyl pyrrolidone and polyethylene glycol 4000 and 6000.
    Adel MS; Geneidi AS; Ali Shoukri R; Saad I
    Pharmazie; 1997 May; 52(5):373-5. PubMed ID: 9183787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting.
    Sawant RR; Torchilin VP
    Mol Membr Biol; 2010 Oct; 27(7):232-46. PubMed ID: 20929339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of casein micelles cross-linked by transglutaminase.
    Smiddy MA; Martin JE; Kelly AL; de Kruif CG; Huppertz T
    J Dairy Sci; 2006 Jun; 89(6):1906-14. PubMed ID: 16702254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Becker nevus with topical flutamide.
    Taheri A; Mansoori P; Sandoval LF; Feldman SR
    J Am Acad Dermatol; 2013 Sep; 69(3):e147-8. PubMed ID: 23957996
    [No Abstract]   [Full Text] [Related]  

  • 12. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
    Lukyanov AN; Torchilin VP
    Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles.
    Bachar M; Mandelbaum A; Portnaya I; Perlstein H; Even-Chen S; Barenholz Y; Danino D
    J Control Release; 2012 Jun; 160(2):164-71. PubMed ID: 22266050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics.
    Elzoghby AO; Helmy MW; Samy WM; Elgindy NA
    Int J Nanomedicine; 2013; 8():1721-32. PubMed ID: 23658490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity.
    Shapira A; Markman G; Assaraf YG; Livney YD
    Nanomedicine; 2010 Aug; 6(4):547-55. PubMed ID: 20100598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of a cationic acrylate polymer with caseins: biphasic effect of Eudragit E100 on the stability of casein micelles.
    Ausar SF; Bianco ID; Castagna LF; Alasino RV; Beltramo DM
    J Agric Food Chem; 2003 Jul; 51(15):4417-23. PubMed ID: 12848519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release.
    Dai J; Lin S; Cheng D; Zou S; Shuai X
    Angew Chem Int Ed Engl; 2011 Sep; 50(40):9404-8. PubMed ID: 21898731
    [No Abstract]   [Full Text] [Related]  

  • 18. Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions.
    Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
    Drug Dev Ind Pharm; 2011 Jul; 37(7):754-64. PubMed ID: 21204753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of disulfide core-crosslinked pluronic nanoparticles as an effective anticancer-drug-delivery system.
    Abdullah-Al-Nahain ; Lee H; Lee YS; Lee KD; Park SY
    Macromol Biosci; 2011 Sep; 11(9):1264-71. PubMed ID: 21717576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in polymeric micelles for drug delivery and tumor targeting.
    Kedar U; Phutane P; Shidhaye S; Kadam V
    Nanomedicine; 2010 Dec; 6(6):714-29. PubMed ID: 20542144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.